Blueblood Ventures Ltd

Blueblood Ventures Ltd has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the Unaudited Standalone Financial Results for the second quarter and half-year ended September 30, 2026. Additionally, the company confirmed the trading window for designated persons, which closed on September 30, 2026, will reopen on November 15, 2026.

Blueblood Ventures Limited's Board of Directors convened on October 9, 2026, approving key appointments and strategic initiatives. M/s. Mahesh Sharma & Associates have been appointed as the Internal Auditor for a five-year term from FY2026-27 to FY2030-31, with a professional fee of ₹325,000 per annum plus applicable taxes. Mr. Chandrashekhar Singh was appointed as an Additional Director in the Non-Executive Independent category. The Board also approved, in principle, the establishment of a branch office in Kolkata at a monthly rent of ₹20,000, noting it as a related-party transaction. Additionally, the company will consider a Debt Assignment Transaction and a potential Share Purchase/Sale of SJM Investments (Delhi) Private Limited.

Blueblood Ventures Limited announced key decisions from its Board of Directors meeting held on October 9, 2026. The board approved the appointment of M/s. Mahesh Sharma & Associates as Internal Auditor for FY2026-27 to FY2030-31 at a fee of ₹325,000 per annum. Mr. Chandrashekhar Singh was appointed as an Additional Director (Non-Executive Independent) effective the same date. The company also approved, in principle, the opening of a branch office in Kolkata at a monthly rent of ₹20,000, noting it as a related party transaction. Additionally, the board approved a Debt Assignment Transaction and may enter into a Share Purchase/Sale transaction of S|M Investments (Delhi) Private Limited.

Blueblood Ventures Limited announced key board decisions from its meeting on October 9, 2026. The company appointed M/s. Mahesh Sharma & Associates as its internal auditor for FY27-FY31 at ₹325,000 per annum plus taxes. Mr. Chandrashekhar Singh was appointed as a Non-Executive Independent Director. The board also approved, in principle, opening a branch office in Kolkata for ₹20,000 monthly rent, a related party transaction. Additionally, a debt assignment transaction and a potential share purchase/sale of SJM Investments (Delhi) Private Limited were approved.

Blueblood Ventures Ltd has announced a Board of Directors meeting scheduled for October 9, 2026. The primary agenda items include the consideration and approval for the appointment of M/s Mahesh Sharma & Associates as the Internal Auditor for a five-year term (FY2026-27 to FY2030-31). Additionally, the board will consider the appointment of Mr. Chandrashekhar Singh as a Director. The meeting will be held at the company's registered office in New Delhi.

Blueblood Ventures Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This measure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will remain closed from Thursday, October 1, 2026, until 48 hours after the declaration of the company's financial results for the quarter and half-year ending September 30, 2026. The specific date for the board meeting to consider these financial results will be communicated separately. This action is a standard procedure to prevent potential insider trading during periods of sensitive financial information disclosure.

Blueblood Ventures Limited has announced that its 19th Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:30 A.M. The meeting will take place at the company's registered office in New Delhi. Key agenda items include the adoption of the standalone audited financial statements for the fiscal year ended March 31, 2026, and the re-appointment of Mr. Suresh Bohra as a Director, who retires by rotation. The Register of Members and Share Transfer Books will be closed from September 23 to September 30, 2026, inclusive.

Blueblood Ventures Ltd announced that its Board of Directors, in a meeting held on September 7, 2026, has decided to convene the Annual General Meeting (AGM) on September 30, 2026. The AGM will take place at 11:30 AM at their Greater Kailash-2, New Delhi office. Additionally, the company will close its Register of Members and Share Transfer books from September 23 to September 30, 2026, inclusive, as per Section 91 of the Companies Act, 2013. The Annual Report for 2025-26 and the AGM notice will be available on the company's website.

Blueblood Ventures Ltd has released its Annual Report for the financial year ended March 31, 2026. The company reported a total revenue of ₹1,10,64,000, an increase from ₹80,08,000 in the previous fiscal year. Profit after tax for FY26 stood at ₹3,26,000, a significant jump from ₹59,000 in FY25. The company cited delays in statutory approvals as a reason for not securing new business. The Directors have not recommended any dividend to reinvest funds for business growth and strengthening working capital. Authorized share capital is ₹3,10,00,000 and paid-up capital is ₹3,00,10,800 as of March 31, 2026.

Blueblood Ventures Ltd announced that its Register of Members and Share Transfer books will be closed from September 23, 2026, to September 30, 2026, inclusive. This closure is in preparation for the Annual General Meeting (AGM) scheduled for September 30, 2026. The AGM will be held at 11:30 AM at their Greater Kailash-2, New Delhi office. The company also confirmed that the Notice of AGM and the Annual Report for 2025-26 will be made available on their website.